During the past decade, Medical Plus s.r.o. conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 32 clinical trials were completed, i.e. on average, 76.2% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 21 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical Plus s.r.o." #1 sponsor was "Pfizer" with 13 trials, followed by "Galapagos NV" with 6 trials sponsored, "Eli Lilly and Company" with 5 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored and "Anika Therapeutics, Inc." with 5 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Plus s.r.o." #1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Alkem Laboratories Ltd" with 1 trials as a collaborator and "ArthroLab Inc." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Medical Plus s.r.o." are "Rheumatoid Arthritis" (19 trials), "Psoriatic Arthritis" (7 trials), "Arthritis, Psoriatic" (6 trials), "Ankylosing Spondylitis" (4 trials) and "Arthritis, Rheumatoid" (3 trials). Many other conditions were trialed in "Medical Plus s.r.o." in a lesser frequency.

Most popular intervention types in "Medical Plus s.r.o." are "Drug" (41 trials), "Biological" (7 trials), "Other" (5 trials), "Device" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Guselkumab" (5 trials), "Tofacitinib" (5 trials), "Filgotinib" (3 trials) and "Methotrexate" (3 trials). Other intervention names were less common.

The vast majority of trials in "Medical Plus s.r.o." are 49 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Medical Plus s.r.o.". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Medical Plus s.r.o., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Medical Plus s.r.o., 0 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".